Intra-Cellular Therapies, Inc.
Intra-Cellular Therapies, Inc. (ITCI) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
itci · stock forecast · 23 analysts (3M) · FMP · updated May 21, 2025
Analyst Rating & Consensus
Based on 23 Wall Street analysts in the past 3 months
Buy
23 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$132
Consensus
$98.50
-25.3% upside
Low
$70.00
Median: $101.5 · Last Close: $131.87
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$98.50
-25.3% upside
High Target
$132
0.1%
Low Target
$70
-46.9%
Current Price
$131.87
as of today
Based on analyst price targets, the ITCI stock price prediction for the next 12 months ranges from $70 to $132. The consensus ITCI price forecast of $98.50 implies -25.3% upside from the current price of $131.87.
Short-Term Price Prediction
BullAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $131.74 | ↓ 0.10% |
1-day model range: $131.59–$131.89. Peak: $131.89 (-0.10%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $136 | +2.8% |
| 2028 | $138 | +4.6% |
| 2029 | $140 | +5.8% |
| 2030 | $141 | +6.6% |
| 2031 | — | +7.1% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ITCI · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-04-02 | Cantor Fitzgerald | Maintains | Neutral→Neutral |
| 2025-02-24 | Mizuho | Downgrade ↓ | Outperform→Neutral |
| 2025-02-21 | Needham | Maintains | Hold→Hold |
| 2025-01-31 | Canaccord Genuity | Downgrade ↓ | Buy→Hold |
| 2025-01-22 | RBC Capital | Downgrade ↓ | Outperform→Sector Perform |
| 2025-01-14 | Piper Sandler | Downgrade ↓ | Overweight→Neutral |
| 2025-01-13 | Needham | Downgrade ↓ | Buy→Hold |
| 2024-11-04 | JP Morgan | Maintains | Overweight→Overweight |
| 2024-10-31 | Needham | Maintains | Buy→Buy |
| 2024-10-30 | Needham | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Intra-Cellular Therapies, Inc. (ITCI) stock. Of the recent 178 rating actions, 7 were upgrades and 21 were downgrades. 23 analysts currently cover ITCI.
Analyst Recommendation Trends
ITCI analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 3 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$926M
↓ 53.3% YoY
Revenue Next Year
$1.4B
↑ 54.7% YoY
EPS This Year
$0.80
EPS Next Year
$4.31
↑ 440.8% YoY
EPS ForecastReported vs Estimated
Analysts forecast ITCI EPS of $0.80 for the current fiscal year, based on estimates from 7 analysts. The ITCI revenue forecast is $926M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The ITCI stock forecast is supported by two independent data sources: analyst consensus ratings from 23 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus ITCI price target is $98.50 (-25.3% upside), with an analyst consensus of Buy.
The ITCI short-term stock prediction for tomorrow is $131.74 (-0.10%). The ITCI stock price prediction for 2027 estimates an average of $136. The ITCI stock prediction for 2030 projects a range of $139–$142.
Intra-Cellular Therapies, Inc. trades on NASDAQ under the ticker ITCI. The ITCI stock outlook for 2027 is broadly positive, supported by a Buy consensus among 61% of covering analysts.
Frequently asked questions
ITCI forecast · 8 questionsAccording to 23 Wall Street analysts, the average 12-month ITCI price target is $98.50, with a high forecast of $132.00 and a low of $70.00. The median price target is shown in the chart above when available. This implies -25.3% potential upside from the current price of $131.87.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.